The 12th pharmacovigilance conference will hear how data protection regulation is impacting pharmacovigilance processes, when the outcomes of measuring the impact of pharmacovigilance activities are expected and possible changes that might follow as well as looking at the new trends in the digital era.
Ask for a Free trial and get access to our last stories
- Health Care
- Market Access
- HTA – policies & practices
- European medicine regulations
- Drug safety issues
- Pricing & Reimbursement
- International medicines agencies
If you are a Payer, Pharmaceutical or Consulting professional our premium data will keep you informed on the regulatory, pricing, market access and cost-effectiveness issues that impact all stakeholders.
an initial 10 day temporary access of APM Health Europe.